Live Breaking News & Updates on Johns Hopkins Sidney Kimmel Cancer Center

Stay updated with breaking news from Johns hopkins sidney kimmel cancer center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Blood test to detect early cancer used on some patients - The San Diego Union-Tribune

New blood tests measure “signals” in the blood to help detect cancer. Experts say more study is needed to determine if the new tests save lives ....

United-states , Phoenix , Arizona , San-diego , California , American , Delfi-firstlook , Peter-bach , Valerie-caro , N-jewel-samadder , Eric-klein , Dennis-barnes

Segmenting the Utility of ADCs in NSCLC: How These Agents Are Affecting Second-Line Standards

Keeping investigators on the edge of their seats, new data from clinical trials evaluating ADCs continue to impress. ....

Washington , United-states , Johns-hopkins-sidney-kimmel-cancer-center , Sibley-memorial-hospital , Make-waves , Cancer-field , Their-own , Prescription-drug-user-fee-act , Blood-brain-barrier , Sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins , News

Dr Levy on the Potential for ADCs in NSCLC

Benjamin Levy, MD, explores the potential role of antibody-drug conjugates in non–small cell lung cancer.

....

Baltimore , Maryland , United-states , Johns-hopkins-university , Benjamin-levy , Johns-hopkins-university-school-of-medicine , Medical-oncology , Johns-hopkins-sidney-kimmel-cancer-center , Sibley-memorial-hospital , Johns-hopkins-university-school ,

Continued ADC Development in NSCLC Necessitates Improved Knowledge of Mechanisms and Biomarker Optimization

Identifying biomarkers and the mechanism of action of antibody-drug conjugates may optimize benefits with these agents in non–small cell lung cancer. ....

Hollywood , California , United-states , Maryland , Johns-hopkins-university , Baltimore , Daiichi-sankyo , Benjamin-levy , Johns-hopkins-university-school-of-medicine , Annual-winter-lung-cancer , Medical-oncology

Dr Levy on Unanswered Questions Regarding the Mechanism of Action of ADCs in NSCLC

Benjamin Levy, MD, discusses the mechanism of action of antibody-drug conjugates in patients with non–small cell lung cancer. ....

Benjamin-levy , Johns-hopkins-university-school-of-medicine , Medical-oncology , Johns-hopkins-sidney-kimmel-cancer-center , Sibley-memorial-hospital , Johns-hopkins-university-school , D , Mechanism-of-action-antibody-drug-conjugates , Patients-with-non-small-cell-lung-cancer ,